title: [Prescribing prednisolone alone in idiopathic facial paralysis and diagnosis within 72 hours of symptom onset].
authors.affiliation: Tayside Centre for General Practice, Division of Community Health Sciences, University of Dundee, Dundee DD2 4BF, Ireland.
authors.forename: V
authors.initials: V
authors.lastname: Madhok
authors.forename: G
authors.initials: G
authors.lastname: Falk
authors.forename: T
authors.initials: T
authors.lastname: Fahey
authors.forename: F M
authors.initials: FM
authors.lastname: Sullivan
mesh_terms: D000212:Acyclovir / Q000008:administration & dosage / Q000009:adverse effects; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage* / Q000009:adverse effects; D000998:Antiviral Agents / Q000008:administration & dosage / Q000009:adverse effects; D020330:Bell Palsy / Q000175:diagnosis / Q000188:drug therapy*; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D006801:Humans; D011239:Prednisolone / Q000008:administration & dosage* / Q000009:adverse effects; D011379:Prognosis; D016032:Randomized Controlled Trials as Topic
chemical_list: D000893:Anti-Inflammatory Agents; D000998:Antiviral Agents; D011239:Prednisolone; D000212:Acyclovir